GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 180 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2018. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $51,000 | -15.0% | 800 | -31.9% | 0.01% | -29.4% |
| Q1 2020 | $60,000 | -36.2% | 1,175 | -0.8% | 0.02% | -22.7% |
| Q4 2019 | $94,000 | -43.7% | 1,185 | -65.6% | 0.02% | -52.2% |
| Q3 2019 | $167,000 | +1.2% | 3,440 | +9.6% | 0.05% | +4.5% |
| Q2 2019 | $165,000 | -0.6% | 3,140 | 0.0% | 0.04% | -12.0% |
| Q1 2019 | $166,000 | +28.7% | 3,140 | 0.0% | 0.05% | +13.6% |
| Q4 2018 | $129,000 | +24.0% | 3,140 | +14.6% | 0.04% | +25.7% |
| Q3 2018 | $104,000 | -58.7% | 2,740 | -57.2% | 0.04% | -56.8% |
| Q4 2017 | $252,000 | – | 6,400 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 383,702 | $14,581,000 | 7.71% |
| Perceptive Advisors | 5,148,910 | $195,658,000 | 5.23% |
| Grace Capital | 312,514 | $11,876,000 | 4.65% |
| NEXTHERA CAPITAL LP | 549,231 | $20,871,000 | 4.00% |
| Asymmetry Capital Management, L.P. | 103,449 | $3,931,000 | 3.63% |
| Camber Capital Management LP | 2,075,000 | $78,850,000 | 3.37% |
| Casdin Capital, LLC | 440,000 | $16,720,000 | 2.03% |
| EMORY UNIVERSITY | 53,951 | $2,050,000 | 1.34% |
| ArchPoint Investors | 129,435 | $4,919,000 | 1.34% |
| Ghost Tree Capital, LLC | 150,000 | $5,700,000 | 1.21% |